Cargando…

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung

To characterise Pseudomonas aeruginosa populations during chronic lung infections of non-cystic fibrosis bronchiectasis patients, we used whole-genome sequencing to 1) assess the diversity of P. aeruginosa and the prevalence of multilineage infections; 2) seek evidence for cross-infection or common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilliam, Yasmin, Moore, Matthew P., Lamont, Iain L., Bilton, Diana, Haworth, Charles S., Foweraker, Juliet, Walshaw, Martin J., Williams, David, Fothergill, Joanne L., De Soyza, Anthony, Winstanley, Craig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898933/ https://www.ncbi.nlm.nih.gov/pubmed/28446558 http://dx.doi.org/10.1183/13993003.02108-2016

Ejemplares similares

Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis()
por: Ashish, Abdul, et al.
Publicado: (2013)

Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections
por: James, Chloe E, et al.
Publicado: (2015)

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
por: Winstanley, Craig, et al.
Publicado: (2016)

Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium
por: Wright, Elli A, et al.
Publicado: (2013)

Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain
por: Williams, David, et al.
Publicado: (2018)

High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections
por: O’Brien, Siobhán, et al.
Publicado: (2017)

Family case studies: absence of Pseudomonas aeruginosa transmission in bronchiectasis
por: Sobala, Ruth, et al.
Publicado: (2022)

Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study
por: Ashish, Abdul, et al.
Publicado: (2013)

Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model
por: Davies, Emily V., et al.
Publicado: (2017)

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
por: Kirchner, Sebastian, et al.
Publicado: (2012)

Transmission, adaptation and geographical spread of the Pseudomonas aeruginosa Liverpool epidemic strain
por: Moore, Matthew P., et al.
Publicado: (2021)

The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung
por: O'Brien, Siobhán, et al.
Publicado: (2017)

Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
por: Blanco-Aparicio, Marina, et al.
Publicado: (2019)

Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain
por: Fothergill, Joanne L, et al.
Publicado: (2007)

Genomics of Diversification of Pseudomonas aeruginosa in Cystic Fibrosis Lung-like Conditions
por: Schick, Alana, et al.
Publicado: (2022)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
por: Hsieh, Meng-Heng, et al.
Publicado: (2018)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study
por: Wang, Hong, et al.
Publicado: (2018)

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
por: Kwok, Wang Chun, et al.
Publicado: (2021)

Comparative Genomics of Isolates of a Pseudomonas aeruginosa Epidemic Strain Associated with Chronic Lung Infections of Cystic Fibrosis Patients
por: Jeukens, Julie, et al.
Publicado: (2014)

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
por: Ramsay, Kay A., et al.
Publicado: (2023)

Influence of Pseudomonas Aeruginosa on Exacerbation in Patients with Bronchiectasis
por: Chawla, Kiran, et al.
Publicado: (2015)

Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis
por: Figueiredo, Mara Rúbia, et al.
Publicado: (2021)

Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa
por: James, Chloe E, et al.
Publicado: (2012)

Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics
por: Martin, Lois W, et al.
Publicado: (2023)

Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review
por: Sousa, Ana Margarida, et al.
Publicado: (2014)

The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
por: Dhand, Rajiv
Publicado: (2018)

Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis
por: Pieters, A., et al.
Publicado: (2019)

Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa
por: Riveiro, Vanessa, et al.
Publicado: (2022)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
por: Serisier, David J, et al.
Publicado: (2013)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance
por: Hasan, Chowdhury M., et al.
Publicado: (2022)

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
por: Blanchette, Christopher M., et al.
Publicado: (2017)

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa
por: Menéndez, Rosario, et al.
Publicado: (2020)

Pseudomonas aeruginosa population genomics among adults with bronchiectasis across Germany
por: Rosenboom, Ilona, et al.
Publicado: (2023)

β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
por: Glen, Karl A., et al.
Publicado: (2021)

Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study
por: Ashish, Abdul, et al.
Publicado: (2012)

Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains
por: Varga, John J., et al.
Publicado: (2015)

The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa
por: Erdmann, Mareike B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4d8iolfk7pp3jdsi65s43oqi9a